Does semaglutide make you fertile, or more fertile than before?

You've been reading that Wegovy makes women more fertile, here's what's actually happening

You may have come across news stories, social media posts, or forum threads claiming that Wegovy or semaglutide causes unexpected pregnancies. Some of those accounts are real. But the mechanism is not a direct fertility drug effect, semaglutide does not stimulate the ovaries or raise reproductive hormones on its own.

What it does is help people lose a meaningful amount of weight. In the STEP 1 clinical trial, published in the New England Journal of Medicine, adults taking semaglutide 2.4mg lost an average of around 15% of their body weight over 68 weeks. That scale of weight reduction can shift the hormonal environment considerably, especially in women whose cycles have been disrupted by excess weight.

Excess adipose tissue produces oestrogen and influences insulin sensitivity, both of which affect ovulation. When weight falls, those hormonal pressures ease. For some women (particularly those with PCOS, where insulin resistance and elevated androgens suppress ovulation) losing 5–10% of body weight can be enough to restart more regular cycles. Semaglutide may help achieve that loss faster and more consistently than diet and exercise alone. The fertility change follows from the weight loss; it is not a separate pharmacological action of the drug. That distinction matters enormously for how you plan treatment. You can read more about how semaglutide works on our main semaglutide page.

The contraception question that catches people off guard

One reason unexpected pregnancies make the news is that ovulation can return before a woman realises her cycles have changed. If someone assumed they were unlikely to conceive based on years of irregular periods, they may not have been using contraception carefully. Semaglutide does not warn them by sending a signal, it simply removes one of the obstacles that had been suppressing fertility.

UK guidance, including the NHS England advice on weight-management injections, is clear: effective contraception is important during treatment. There is also a specific note about oral contraceptive pills and tirzepatide (a different GLP-1 medicine), but for semaglutide specifically, the main precaution is around the fact that returning fertility can outpace a woman's awareness of it.

The MHRA also advises a wash-out period before trying to conceive. Semaglutide is not recommended in pregnancy; it is not recommended while breastfeeding; it is not recommended for anyone under 18. If your circumstances involve any of these, those are conversations to have with a prescriber before starting, not after. Our frequently asked questions page covers related safety queries if you want a quick overview before booking a consultation.

Does this mean Wegovy could help with PCOS or ovulation problems?

It might, indirectly, but it is not licensed or prescribed for that purpose, and the evidence for using it specifically as a fertility aid is not yet strong enough to make that claim. What the research does support is that weight loss improves metabolic and hormonal markers in women with PCOS, and that GLP-1 medicines can produce clinically significant weight loss for people who qualify for them.

If improving fertility is part of your reason for considering weight management treatment, that context belongs in your consultation. A prescriber can think through whether treatment is appropriate, what contraception approach makes sense in the meantime, and what the transition plan looks like if conception becomes your goal. There is more information about eligibility and treatment options on our weight loss overview page. It is also worth reading about some of the other questions people have alongside fertility discussions, such as whether semaglutide could affect fertility negatively, the answer is reassuring but worth understanding fully.

Getting semaglutide safely if fertility context is part of your picture

Wegovy is a prescription-only medicine. In the UK, the legal route to it runs through a clinical assessment, there is no version of this that skips that step. At nume, a GPhC-registered Independent Prescriber reads your consultation personally on the day you submit it; no software makes the clinical call. If approved, your treatment is dispatched the same day (for orders placed before 12pm, Monday to Friday) and arrives the next working day via DPD, in plain unbranded packaging, nothing on the outside indicates what's inside.

If your consultation raises fertility-related questions, that is exactly the kind of nuance our prescribers are there to work through. People often arrive with broader questions too, for instance whether semaglutide can be made at home or compounded, and understanding why that matters for safety is part of making an informed choice. It is also worth knowing that products marketed online without clinical oversight are a genuine safety risk, the MHRA has warned repeatedly about counterfeit weight-loss pens circulating without a prescription. Patients sometimes ask about digestive side effects during treatment, and if you are wondering whether semaglutide can cause flatulence or want a fuller picture of why semaglutide can leave some people feeling gassy, both are covered in detail on their own pages. A quick check on the GPhC pharmacy register confirms whether any online pharmacy is properly regulated before you hand over personal or health information. For context on where to access Wegovy from a regulated UK pharmacy, our guide to buying Wegovy in the UK explains what to look for and what to avoid.

If any of this raises further questions (about dosing timelines, stopping treatment before trying to conceive, or something else entirely) our team is reachable seven days a week.